Neuropathic pain is a type of pain caused by damage or problems in the nerves. Unlike pain from a cut or injury, nerve pain comes from the nervous system itself. It can feel like burning, tingling, electric shocks, or sharp stabbing sensations.
For many people, this kind of pain can last for months or even years and can make everyday life very difficult. In the United States alone, more than 20 million people live with neuropathic pain. Doctors can sometimes identify the cause, such as diabetes, infections, injuries, or certain diseases that damage nerves.
However, in many cases the reason for the pain is not clear. About one quarter of neuropathic pain cases fall into this uncertain category. This condition is known as cryptogenic sensory polyneuropathy, often shortened to CSPN.
The word cryptogenic means the cause is unknown, while polyneuropathy refers to damage affecting many nerves in the body. People with CSPN usually feel pain, numbness, or tingling in their feet or hands. Over time the discomfort may spread or become stronger. Because the cause is unknown, doctors often struggle to choose the most effective treatment.
There are several medications that may help relieve nerve pain, but until recently there was limited evidence showing which ones work best for CSPN. To better understand this issue, researchers at the University of Missouri carried out a large clinical study comparing several commonly used medications.
The research team wanted to find out which drugs provided the most relief for patients with this mysterious condition. The study included 402 adults aged 30 years or older who were living with significant nerve pain. Before the study began, each participant rated their pain on a scale from zero to ten.
A score of zero meant no pain, while ten represented the worst pain imaginable. Everyone in the study reported pain at a level of four or higher, meaning they were experiencing moderate to severe discomfort. The participants were then assigned to receive one of four medications that doctors often prescribe for nerve pain.
These drugs were nortriptyline, duloxetine, pregabalin, and mexiletine. Although they are all used to treat nerve-related pain, they were originally developed for different medical purposes. Nortriptyline is an older antidepressant that belongs to a group of medications known as tricyclic antidepressants.
It works by changing how certain chemical signals move between nerve cells in the brain and spinal cord. Duloxetine is another antidepressant but belongs to a newer class called serotonin-norepinephrine reuptake inhibitors, or SNRIs. It also affects brain chemicals involved in pain and mood.
Pregabalin was first designed as a medication to prevent seizures in people with epilepsy, but doctors later discovered that it can also reduce nerve pain in some patients. Mexiletine is quite different from the others.
It was originally developed to treat irregular heart rhythms, but it can sometimes help control nerve pain by affecting how electrical signals move through nerve cells. During the 12-week study period, the researchers carefully monitored how patients responded to each medication.
They measured whether pain improved and also recorded how many patients continued taking the drug or stopped because of side effects or lack of benefit. The results showed that some medications performed better than others. Nortriptyline had the highest success rate among the four drugs.
About 25 percent of patients taking nortriptyline reported meaningful relief from their nerve pain. Although some patients stopped taking the medication, the quit rate was relatively moderate at 38 percent.
Duloxetine produced similar results. It helped about 23 percent of patients and had the lowest drop-out rate of all the drugs, with 37 percent of participants discontinuing treatment. Pregabalin, which is widely used for nerve pain, showed less success in this particular study. Only about 15 percent of patients reported clear pain relief.
Mexiletine had the highest number of patients stopping the treatment, with 58 percent choosing to discontinue the drug during the study period. This high quit rate suggests that many patients either experienced side effects or did not feel enough improvement to continue taking it.
Although none of the medications worked for everyone, the researchers concluded that nortriptyline and duloxetine appeared to offer the best balance between pain relief and patient tolerance. Based on these findings, the scientists suggest that doctors may want to consider these two drugs as first treatment options for people diagnosed with CSPN.
However, they also emphasize that treatment should always be tailored to each patient. Different individuals respond differently to medications, and what works well for one person may not work for another. The researchers also noted that other drugs are sometimes used to treat nerve pain.
For example, gabapentin and venlafaxine are commonly prescribed in clinical practice. Some medicines that affect sodium channels in nerve cells may also help reduce pain signals traveling through the nerves. The team believes that future research should compare these additional medications as well.
More studies could help doctors understand which treatments work best for different groups of patients. Better evidence could also lead to clearer medical guidelines for managing CSPN, a condition that has long puzzled doctors.
The findings of this research were published in the medical journal JAMA Neurology and the study was led by Dr. Richard Barohn and his colleagues. This work represents an important step toward improving care for people living with chronic nerve pain.
As scientists continue to study CSPN and related nerve disorders, doctors may eventually gain better tools to relieve pain and improve quality of life for millions of patients around the world.
If you care about pain, please read studies about vitamin K deficiency linked to hip fractures in old people, and these vitamins could help reduce bone fracture risk.
For more health information, please see recent studies that Krill oil could improve muscle health in older people, and eating yogurt linked to lower frailty in older people.
Copyright © 2026 Knowridge Science Report. All rights reserved.
